Our primary users are frontline healthcare professionals — the ones who carry the weight of life-or-death decisions in hospitals, labs, and clinics that don’t always have the resources they need. We’re talking about junior pathologists in district hospitals, general practitioners in rural towns, and medical lab scientists trying to do more with very little. These are the people who often have biopsy slides in hand but no specialist to interpret them. They’re not lacking in skill —they’re lacking in support, in speed, and in the kind of connected ecosystem that turns a local diagnosis into a collaborative one. Take Dr. Fola, for example — a young pathologist working in a regional hospital in southwestern Nigeria. She has a backlog of slides, an ageing microscope, and no senior colleagues on site. With OncoLens, she’s no longer alone. She can slide a sample into the smart reader, run an AI-powered diagnostic suggestion, and consult virtually with experts around the world — all from her desk. Our secondary beneficiaries are, of course, the patients. The mothers, brothers, aunties, students, and farmers who’ve walked into a clinic with pain, fear, and uncertainty. By enabling faster, smarter, and more confident diagnoses, we’re giving these patients something many currently don’t have: a chance — a real chance at catching cancer early and surviving it. 